logo
  • genedrive.com
  • About us
    • Company profile
    • Board of directors
    • Advisors
  • Our product
  • News & Events
    • Press releases
    • Events
    • Media
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • AIM Rule 26
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Analyst notes
    • Constitutional documents
    • Investor news
    • Corporate governance
    • COVID 19
    • Investor contacts
    • Company information

Company information

Home > Investor relations > Company information

Registered Office, Head Office and Business Address of the Directors and Principal Trading Address:


48 Grafton St
Manchester
M13 9XX
 

Admission Document

Articles of Association

Annual & Half Year Reports

Latest reports

share price graph

16 June 2020

Investor Presentation June 2020

View all reports >

Investor News

Wednesday September 30, 2020

Proactive news headlines: Iconic Labs, Sensyne Health, Genedrive, S&U...

Wednesday September 30, 2020

Malvern International tanks after AIM suspension

Wednesday September 30, 2020

Genedrive's COVID-19 test kit approved for sale in South Africa

View all news >

  • Privacy
  • Terms of use
  • Site map

© 2017-20 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose